Fresenius Kabi Oncology Limited Bortezomib Export Data — India (DGFT 2022–2026)

Name: Fresenius Kabi Oncology Limited Bortezomib Export Records India — #5 Exporter, 99 Shipments, $803.7K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Bortezomib

India Pharmaceutical Trade Intelligence

$21.9M200 Suppliers109 CountriesHS 30049049

ExportsIndia → BRAZIL28.3%India → UNITED STATES25.4%

ImportsITALY → India$200.0K UNITED STATES → India$72.1K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: EUGIA US

Fresenius Kabi Oncology Limited — Bortezomib Exporter #5 | $803.7K Trade Value | TransData Nexus | TransData Nexus

Fresenius Kabi Oncology Limited — Bortezomib Exporter Profile

Indian Pharmaceutical Exporter · #5 for Bortezomib · $803.7K export value · DGFT Verified

Fresenius Kabi Oncology Limited is the #5 Indian exporter of Bortezomib with $803.7K in export value and 99 verified shipments. Fresenius Kabi Oncology Limited holds a 3.7% market share in Bortezomib exports across 10 countries. The company exports 16 pharmaceutical products worth $117.2M across 3 therapeutic categories.

Fresenius Kabi Oncology Limited — Bortezomib Export Profile: Buyers & Destinations

Fresenius Kabi Oncology Limited Bortezomib export treemap — buyers and destination countries | TransData Nexus

Where Does Fresenius Kabi Oncology Limited Export Bortezomib?

Country	Value	Shipments	Share
GERMANY	$653.3K	76	81.8%
CHILE	$92.5K	6	11.6%
THAILAND	$16.5K	4	2.1%
HUNGARY	$9.1K	5	1.1%
COSTA RICA	$8.4K	1

Who Are the Top Buyers of Bortezomib from Fresenius Kabi Oncology Limited?

Buyer	Country	Value	Orders
FRESENIUS KABI DEUTSCHLAND GMBH	GERMANY	$604.4K	66
FRESENIUS KABI CHILE LTDA.	CHILE	$49.4K	2
FRESENIUS KABI DEUTSCHLAND GMB	GERMANY	$49.0K	10
FRESENIUS KABI CHILE LIMITEDA.	CHILE	$19.9K	1
FRESENIUS KABI CHILE LIMITEDA	CHILE	$16.8K	2
BIO TECH PHARMA S.A	COSTA RICA	$16.7K	2
FRESENIUS KABI CHILE LTDA	CHILE	$6.4K	1
EUROFINS ANALYTICAL SERVICES HUNGAR	HUNGARY	$5.7K	3
FRESENIUS KABI THAILAND LIMITED	THAILAND	$5.7K	1
FRESENIUS KABI (SINGAPORE) PTE LTD	SINGAPORE	$5.6K	2

Fresenius Kabi Oncology Limited supplies Bortezomib to 19 buyers globally. The largest buyer is FRESENIUS KABI DEUTSCHLAND GMBH (GERMANY), followed by FRESENIUS KABI CHILE LTDA. (CHILE) and FRESENIUS KABI DEUTSCHLAND GMB (GERMANY). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Bortezomib Formulations Does Fresenius Kabi Oncology Limited Export?

Product Description / Formulation	Value	Shipments
BORTEZOMIB FRESENIUS KABI INJECTION 3.5M	$178.7K	19
BORTEZOMIB FRESENIUS KABI INJ. 3.5MG/VIA	$104.3K	16
BORTEZOMIB FRESENIUS KABI INJ. 3.5MG/VIAL,BATCH NO.87240491AA,87240503AG,MFG.DT.11/2024,12/2024, EXP.DT.10/2026,11/2026	$50.0K	1
BORTEZOMIB FOR INJ. 3.5 MG/VIAL (BATCH NO. 87240503AC MFG. DT. 12/2024 EXP. DT.11/2026)	$26.4K	1
BORTEZOMIB FRESENIUS KABI INJ.3.5MG/VIALB.NO.87240185ABMFG.DT.05/2024 EXP.DT.04/2026	$26.3K	1
BORTEZOMIB FRESENIUS KABI INJ. 3.5MG/VIAL BATCH NO. 87230371AA MANUFACTURING . DT. 08/2023EXP. DT. 07/2025	$24.5K	1
BORTEZOMIB FOR INJ. 3.5 MG/VIAL BATCH NO. 87240125AE, MFG. DT. 04/2024, EXP. DT.03/2026	$23.0K	1
BORTEZOMIB FOR INJ. 3.5 MG/VIAL BATCH NO. 87230507AD MFG. DT. 12/2023 EXP. DT.11/2025NOS	$19.9K	1
BORTEZOMIB FRESENIUS KABI INJ. 3.5MG/VIAL BATCH NO. 87230418AA MANUFACTURING . DT. 09/2023 EXP. DT. 08/2025	$17.5K	1
BORTEZOMIB FRESENIUS KABI INJ. 3.5MG/VIAL BATCH NO. 87230507AB MFG. DT. 12/2023 EXP. DT. 11/2025VLS	$16.2K	1

Fresenius Kabi Oncology Limited exports 65 distinct Bortezomib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is BORTEZOMIB FRESENIUS KABI INJECTION 3.5M with 19 shipments worth $178.7K.

How Does Fresenius Kabi Oncology Limited Compare to Nearest Bortezomib Exporters?

Exporters ranked immediately above and below #5 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$2.9M	57	5	$50.0K
4	VENUS REMEDIES LIMITED	$864.3K	44	16	$19.6K
5	FRESENIUS KABI ONCOLOGY LIMITED ★	$803.7K	99	10	$8.1K
6	DR REDDYS LABORATORIES LIMITED	$500.0K	10	6	$50.0K
7	DR.REDDY'S LABORATORIES LTD	$400.0K	8	2	$50.0K

Fresenius Kabi Oncology Limited ranks #5 among 200 Indian Bortezomib exporters. Average shipment value of $8.1K compared to the market average of $68.4K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and VENUS REMEDIES LIMITED.

Which Indian Ports Ship Bortezomib Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	263	19.0%
SAHAR AIR	229	16.6%
DELHI AIR CARGO ACC (INDEL4)	168	12.1%
DELHI AIR	148	10.7%
HYDERABAD ACC (INHYD4)	82	5.9%
HYDERABAD AIR	82	5.9%
Bombay Air	62	4.5%
Bombay Air Cargo	32	2.3%

Geopolitical & Trade Policy Impact on Fresenius Kabi Oncology Limited's Bortezomib Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like FKOL. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing maritime carriers to suspend bookings and reroute vessels around the Cape of Good Hope. These changes have resulted in increased freight charges and extended transit times, posing significant risks to time-sensitive pharmaceutical shipments. The Pharmaceutical Export Promotion Council of India (Pharmexcil) estimates potential losses ranging from ₹2,500 crore to ₹5,000 crore due to these disruptions. (fortuneindia.com)

Conversely, U.S.-China trade tensions have created openings for Indian pharmaceutical companies. The U.S. has imposed tariffs on Chinese goods, including pharmaceuticals, prompting American importers to seek alternative suppliers. This shift has benefited Indian exporters, as evidenced by the U.S. accounting for approximately 34.5% of India's pharma exports, valued at around $10.5 billion. (actizaindustry.com) However, the U.S. administration's fluctuating tariff policies, including threats of increased tariffs on pharmaceutical imports, necessitate vigilance and adaptability from exporters like FKOL. (lemonde.fr)

In the European Union, regulatory changes such as the Falsified Medicines Directive (FMD) impose stringent requirements on pharmaceutical imports. Compliance with these regulations demands significant investment in serialization and traceability systems. For FKOL, ensuring adherence to such standards is crucial to maintaining access to the lucrative EU market and upholding its reputation for quality and reliability.

Fresenius Kabi Oncology Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the FDA and WHO emphasizing Good Manufacturing Practices (GMP) compliance. Indian exporters, including FKOL, must navigate this evolving landscape to sustain their market positions. Notably, the FDA has increased inspections of Indian manufacturing facilities, with over 200 inspections conducted in 2023 and plans to escalate this number in 2024. (fact.net.in)

FKOL's commitment to quality is evident in its state-of-the-art Research & Development center in Gurgaon, India. The facility focuses on developing next-generation cytotoxic and cytostatic therapies, ensuring that products meet the highest quality standards irrespective of the target market. (fresenius-kabi-oncology.com) This proactive approach to quality assurance positions FKOL favorably in a competitive and regulated global market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Bortezomib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Fresenius Kabi Oncology Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 99 individual customs records matching Fresenius Kabi Oncology Limited exporting Bortezomib, covering 65 formulations to 10 countries via 19 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 109+ countries, 498+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Bortezomib

Bortezomib

Fresenius Kabi Oncology Limited — Bortezomib Exporter Profile

Fresenius Kabi Oncology Limited — Bortezomib Export Profile: Buyers & Destinations

Where Does Fresenius Kabi Oncology Limited Export Bortezomib?

Who Are the Top Buyers of Bortezomib from Fresenius Kabi Oncology Limited?

What Is India's Total Bortezomib Export Value and How Much Does Fresenius Kabi Oncology Limited Contribute?

What Is the Average Shipment Value for Fresenius Kabi Oncology Limited's Bortezomib Exports?

How Does Fresenius Kabi Oncology Limited Compare to Other Indian Bortezomib Exporters?

What Bortezomib Formulations Does Fresenius Kabi Oncology Limited Export?

Regulatory Requirements: Exporting Bortezomib to Key Markets

Germany — BfArM/EMA

How Does Fresenius Kabi Oncology Limited Compare to Nearest Bortezomib Exporters?

Which Indian Ports Ship Bortezomib Exports?

What Other Advanced Oncology Products Does Fresenius Kabi Oncology Limited Export?

Bortezomib — Export Intelligence Video

Geopolitical & Trade Policy Impact on Fresenius Kabi Oncology Limited's Bortezomib Exports

Fresenius Kabi Oncology Limited — Regulatory Compliance & Quality Standards

About Fresenius Kabi Oncology Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Bortezomib Export Data from Fresenius Kabi Oncology Limited

Bortezomib Stats

Company Overview

Top Products by Fresenius Kabi Oncology Limited

Related Analysis

Need Detailed Export Data?

Data Source